SS

Syamala Somisetty

Director DIN 06486407
DIN 06486407 First appointment Feb 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Syamala Somisetty

Data last updated:

Syamala Somisetty was a Director at Charmvera Healthcare Private Limited (from 2013) and Managing Director at Avyakta Pharma Private Limited (from 2017).

DIN 06486407
First Appointment 20 Feb 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Charmvera Healthcare Private Limited U24301AP2013PTC085858
Director20 Feb 20132013Strike Off
Avyakta Pharma Private Limited U36999AP2017PTC106903
Managing Director24 Oct 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Charmvera Healthcare Private Limited
Avyakta Pharma Private Limited
Premium access

Shareholding and investment profile for Syamala Somisetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syamala Somisetty

Syamala Somisetty was first appointed on 20 Feb 2013 as Director at Charmvera Healthcare Private Limited. The most recent appointment on record is 24 Oct 2017 at Avyakta Pharma Private Limited.

Syamala Somisetty held 2 earlier board appointments: Charmvera Healthcare Private Limited (Director, from 20 Feb 2013); Avyakta Pharma Private Limited (Managing Director, from 24 Oct 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available